NCT00056147 Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease Status COMPLETED Phase PHASE2
NCT00043342 Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT00043316 Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT00043225 The Role of Bacteria and Genetic Variations in Cystic Fibrosis Status COMPLETED Phase N/A
NCT00034515 A Study in Adult and Pediatric Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT00027183 Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa Status COMPLETED Phase N/A
NCT00023465 Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging Status UNKNOWN Phase N/A
NCT00016744 Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis) Status COMPLETED Phase PHASE1/PHASE2
NCT00016445 Phase II Study of Growth Hormone in Children With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT00014781 Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis Status COMPLETED Phase N/A
NCT00014768 Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis Status TERMINATED Phase N/A
NCT00006280 A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT00006273 Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis Status UNKNOWN Phase N/A